Sylentis

Tivanisirán / SYL1001

Biodrugs/ Drugs
Blood and Lymphatic systems
Cancer
Dry Eye Syndrome
3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical